We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now


It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

CYTH Cyclo Therapeutics Inc

-0.02 (-1.52%)
Dec 08 2023 - Closed
Delayed by 15 minutes


Draw Mode:

Volume 20,578
Bid Price 1.04
Ask Price 1.34
News -
Day High 1.35


52 Week Range


Day Low 1.25
Company Name Stock Ticker Symbol Market Type
Cyclo Therapeutics Inc CYTH NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.02 -1.52% 1.30 17:06:11
Open Price Low Price High Price Close Price Prev Close
1.35 1.25 1.35 1.30 1.32
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
217 20,578 $ 1.28 $ 26,323 - 0.68 - 2.57
Last Trade Time Type Quantity Stock Price Currency
17:59:47 8 $ 1.32 USD

Cyclo Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
29.55M 22.73M - 1.38M -15.45M -0.68 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Cyclo Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No CYTH Message Board. Create One! See More Posts on CYTH Message Board See More Message Board Posts

Historical CYTH Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week1.541.551.251.3637,314-0.24-15.58%
1 Month1.361.551.13081.3541,330-0.06-4.41%
3 Months1.821.860.89241.3354,934-0.52-28.57%
6 Months1.502.570.89241.6370,146-0.20-13.33%
1 Year1.772.570.681.4091,639-0.47-26.55%
3 Years4.1917.750.686.66242,965-2.89-68.97%
5 Years4.1917.750.686.66242,965-2.89-68.97%

Cyclo Therapeutics Description

Cyclo Therapeutics Inc is a clinical-stage biotechnology firm. The company develops cyclodextrin-based products for the treatment of disease. Its lead drug candidate, Trappsol Cyclo, treats Niemann-Pick Type C disease (NPC). Its other products include Trappsol HPB, Trappsol Fine Chemical, and Aquaplex.

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 |